Page last updated: 2024-09-05
asimadoline and ebastine
asimadoline has been researched along with ebastine in 1 studies
Compound Research Comparison
Studies (asimadoline) | Trials (asimadoline) | Recent Studies (post-2010) (asimadoline) | Studies (ebastine) | Trials (ebastine) | Recent Studies (post-2010) (ebastine) |
---|---|---|---|---|---|
43 | 9 | 11 | 237 | 75 | 58 |
Protein Interaction Comparison
Protein | Taxonomy | asimadoline (IC50) | ebastine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.2375 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.5591 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 1.0575 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.8101 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.4603 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.786 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.8279 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.5 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.047 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.3378 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.8316 | |
Adenosine receptor A3 | Homo sapiens (human) | 3.1953 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.92 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.8734 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.1048 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 2.5455 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.605 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.1871 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.7389 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.2757 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.6475 | |
Substance-K receptor | Homo sapiens (human) | 1.9329 | |
D(1A) dopamine receptor | Homo sapiens (human) | 1.1929 | |
D(4) dopamine receptor | Homo sapiens (human) | 1.2996 | |
Acetylcholinesterase | Homo sapiens (human) | 7.4799 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.183 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.4603 | |
Histamine H2 receptor | Homo sapiens (human) | 2.9157 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.9771 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0904 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.2375 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.047 | |
Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.045 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.2287 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.183 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0283 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.183 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.1216 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.3126 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.1871 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.1974 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0987 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.152 | |
5-hydroxytryptamine receptor 4 | Homo sapiens (human) | 0.061 | |
Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 0.1048 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Other Studies
1 other study(ies) available for asimadoline and ebastine
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |